The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,512.25 firm fixed-price purchase order to Life Technologies Corporation of Carlsbad, California. As the prime contractor, Life Technologies will provide products or services to NIH NCATS between August 31 and October 1, 2023. The award is not associated with a multiple award contract vehicle. No subcontractors or set aside designations were indicated....
The National Institute on Drug Abuse (NIDA), on behalf of the National Center for Advancing Translational Sciences (NCATS), awarded a $99,000 firm fixed-price purchase order to Life Technologies Corporation, doing business as Thermo Fisher Scientific, to independently provide services to obtain kinases' percent inhibition for 5,000 data points at one concentration and 400 IC50 curves of malaria compounds. This non-competitive acquisition leverages Life Technologies' specialized expertise in...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $12,000 purchase order contract to Life Technologies Corporation. The contract has a period of performance from December 6, 2023 through January 6, 2024 for products or services to be delivered to a location in Grand Island, New York. As the prime contractor, Life Technologies Corporation will fulfill the contract requirements without the use of major...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed price purchase order to Fisher Scientific Company L.L.C. valued at $24,010.95 to provide multiple formulation-related laboratory tools and equipment. The solicitation requested brand name or equal laboratory items to support the agency's research and development efforts. Performance will take place in Potomac, Maryland over a three-month period...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $32,986.00 firm fixed price purchase order to Life Technologies Corporation, a for-profit manufacturer, for an iBright FL 1500 Imaging System. This non-competitive award was issued under simplified acquisition procedures without a set-aside designation. The solicitation was posted on March 30, 2020 and the award was made on April 8, 2020 for delivery within 6...
This is a $80,568 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Life Technologies Corporation, a division of Thermo Fisher Scientific, to conduct testing of compounds against a panel of kinase assays. The contract was awarded in response to a full and open competition under simplified acquisition procedures, with no set-aside designation. The work supports the translational research initiatives of the National Center for...
This is a $12,561 firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of ESSENTIAL 6 - MEDIUM RAPID PROTOTYPING LIQUID (BAG) for NCATS, with a completion date of April 17, 2024. This contract was not set aside for...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $150,000.00 firm fixed-price purchase order to 3Dnamics Inc., a biotechnology company, for services related to the differentiation and characterization of induced pluripotent stem cell (iPSC) lines. This non-competitive commercial item acquisition was conducted under simplified acquisition procedures without a small business set-aside. The services...
This $24,000 firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Cellecta, Inc. Cellecta is a for-profit manufacturer of specialty genetic screening products and services used in medical research and drug discovery. The contract does not have a small business set-aside designation. Cellecta frequently partners as the prime contractor to provide CRISPR, RNAi, and other genomic...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $74,811 delivery order against Government Scientific Source Inc.'s Multiple Award Schedule contract. Under this firm fixed price order, GSS will provide 10X Genomics Visium CytoAssist products and services to NIH/NCATS from August 11 to September 10, 2023. As the lead federal agency supporting applied research to accelerate medical product development,...
The National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), awarded a $23,940.00 firm-fixed-price purchase order to Life Technologies Corporation, a division of Thermo Fisher Scientific, for a View RNA in situ hybridization (ISH) cell assay kit. This acquisition supports NCATS' Cooperative Research and Development Agreement (CRADA) for Alagille syndrome (ALGS) research, specifically to screen compound libraries for activators of the JAG1 mRNA, which is a potential therapeutic target for this rare genetic disorder. The acquisition was conducted under simplified acquisition procedures and was not set aside for small businesses. Life Technologies Corporation, as a prime contractor, has a history of delivering specialized scientific equipment, reagents, and related services to various federal agencies, including the NIH, Department of Defense, Department of Agriculture, and Department of Justice.